AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Operating Cash Flow | -43.63M | -55.84M | -70.21M | -160.59M | |
| Free Cash Flow | -43.63M | -55.84M | -70.21M | -160.59M | |
| Investing Cash Flow | 0.00 | 0.00 | -192.47M | -71.23M | |
| Financing Cash Flow | 169.72M | 42.86M | 186.58M | 203.06M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--